All Stories

  1. High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter study

    Article • Expert Review of Gastroenterology & Hepatology, June 2019, Taylor & Francis

    Professor Kadry Elsaeed, Dr Heba Omar, Mohamed Shaker , Yehia El Shazly, Mohamed El Kassas

  2. Ritonavir-boosted paritaprevir, ombitasvir plus ribavirin could improve eGFR in patients with renal impairment and HCV: an Egyptian cohort

    Article • Expert Review of Gastroenterology & Hepatology, November 2018, Taylor & Francis

    Professor Kadry Elsaeed, Dr Heba Omar

  3. An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens

    Article • Expert Review of Gastroenterology & Hepatology, May 2018, Taylor & Francis

    Professor Kadry Elsaeed, Yehia El Shazly